Thus, this humanized monoclonal antibody against CCL21 may be an effective agent for diagnosis of actively inflamed bowel and may perhaps be a therapeutic agent to prevent relapse of IBD. The gene discussed is CCL21; the disease is inflammatory bowel disease.